FREE TRIAL - NO CARD NEEDED
Pubrio gives your team the data, timing, and tools to reach the right prospects before the competition does.
Company & people search
Filter 560M+ contacts by role, industry, tech stack & more.
Sequences
Automate multi-step outreach without losing the personal touch.
Market signals
Stay ahead of every market shift. Pubrio Signals watches companies for you and delivers the right intelligence.
Start your free trial
Join 9,000+ revenue teams already using Pubrio.
No credit card · Cancel anytime · GDPR safe
Already have an account?Log in
Celltrion Healthcare Co.,Ltd.
South Korea · Pharmaceuticals
Pharmaceuticals
Biotechnology
Health Care
Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. For additional information on our guidelines, please visit: https://bit.ly/3QyOyt7
1999
Founded
Pharmaceuticals
Industry
South Korea
Location
14,204,727
Ranking
2,400 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
